This Phase III clinical trial will evaluate the effectiveness of Cimzia (Certolizumab Pegol) in patients who have moderate to severe Crohn's disease. Researchers are currently recruiting patients age 18 to 75 who have show intolerance or insufficient progress using other Crohn's treatments.
Read moreWhen doctors encounter a chronic disease, that tends to be where they put their focus - for example, to help an organ work more effectively... Read more »
The title of this SharePost is a direct quote from three French researchers who investigated the relationship between cigarette smoking and... Read more »
Read more about Tom's comic and his creative process during the 24 Hour Comic Challenge Read more »
Results from a new clinical trial show that a new medication for treating severe Crohn's disease is effective at controlling symptoms of the disease.... Read more »
A medication currently being tested to treat Crohn's disease could also help ease a severe form of spinal arthritis called ankylosing spondylitis... Read more »
Researchers say there is another good reason to stop smoking--Crohn's patients who smoke may be more likely to need surgery. In a recent study,... Read more »
Read more about Tom's comic and the creative process during the 24 Hour Comic Challenge Read more »